United Therapeutics Corporation (UTHR) Reports Third Quarter 2009 Financial Results
10/29/2009 8:32:18 AM
More...
|
United Therapeutics Corporation (UTHR) Reports Second Quarter 2009 Financial Results
7/31/2009 9:21:29 AM
More...
|
United Therapeutics Corporation (UTHR) Release: FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
7/30/2009 12:00:06 PM
More...
|
United Therapeutics Corporation (UTHR) to Announce Second Quarter 2009 Financial Results Before Market Open on Friday, July 31, 2009
7/24/2009 8:31:23 AM
More...
|
United Therapeutics Corporation (UTHR) Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
6/9/2009 10:05:17 AM
More...
|
United Therapeutics Corporation (UTHR): Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
6/9/2009 9:14:51 AM
More...
|
United Therapeutics Corporation (UTHR) Gets FDA Nod for Oral PAH Drug
5/26/2009 7:07:15 AM
More...
|
United Therapeutics Corporation (UTHR) Reports First Quarter 2009 Financial Results
5/4/2009 8:22:13 AM
More...
|
FDA Extends Action Date for United Therapeutics Corporation (UTHR)'s Inhaled Treprostinil (Tyvaso) New Drug Application by Three Months
4/29/2009 7:49:42 AM
More...
|
United Therapeutics Corporation (UTHR) to Announce 2009 First Quarter Financial Results Before Market Open on Friday, May 1, 2009
4/24/2009 12:14:06 PM
More...
|
|